Context: Use of BRAF mutation in papillary thyroid cancer (PTC) has the potential to improve
risk stratification of this cancer. Objective: The objective of the study was to investigate the …

Importance BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its
role in PTC-related patient mortality has not been established. Objective To investigate the …

Objectives. We examined the associations of clinicians’ implicit attitudes about race with
visit communication and patient ratings of care. Methods. In a cross-sectional study of 40 …

Purpose To investigate the prognostic value of BRAF V600E mutation for the recurrence of
papillary thyroid cancer (PTC).

OBJECTIVE: The objective of this review was to analyze published contemporary oncologic
and reproductive outcomes in women with endometrial hyperplasia or cancer undergoing …

Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …

OBJECTIVE: To characterize the immunodeficiency in ataxia-telangiectasia (AT) and to
determine whether the immunodeficiency is progressive and associated with increased …

Purpose This multi-institutional phase I trial was designed to determine the maximum-tolerated
dose (MTD) of cilengitide (EMD 121974) and to evaluate the use of perfusion magnetic …

Purpose This study investigated the utility of BRAF mutation testing of thyroid fine-needle
aspiration biopsy (FNAB) specimens for preoperative risk stratification in papillary thyroid …

BACKGROUND Low health literacy (HL) is associated with poor healthcare outcomes;
mechanisms for these associations remain unclear. OBJECTIVE To elucidate how HL influences …